|
INTS7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.574400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.236400E-03 |
| Normal-vs-Stage2 |
8.425400E-01 |
| Normal-vs-Stage3 |
1.112020E-01 |
| Normal-vs-Stage4 |
3.798800E-01 |
| Stage1-vs-Stage2 |
1.924360E-01 |
| Stage1-vs-Stage3 |
5.724100E-03 |
| Stage1-vs-Stage4 |
1.216440E-01 |
| Stage2-vs-Stage3 |
1.753560E-01 |
| Stage2-vs-Stage4 |
3.099000E-01 |
| Stage3-vs-Stage4 |
9.571200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.603030E-01 |
| Normal-vs-AfricanAmerican |
2.772800E-01 |
| Normal-vs-Asian |
4.075600E-01 |
| Caucasian-vs-AfricanAmerican |
9.723600E-01 |
| Caucasian-vs-Asian |
8.613900E-02 |
| AfricanAmerican-vs-Asian |
3.109000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.026010E-02 |
| Normal-vs-Female |
6.742400E-02 |
| Male-vs-Female |
3.783900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.924800E-01 |
| Normal-vs-Extreme_Weight |
4.579800E-04 |
| Normal-vs-Obese |
7.813200E-01 |
| Normal-vs-Extreme_Obese |
6.062200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.489800E-02 |
| Normal_Weight-vs-Obese |
5.923400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.128200E-01 |
| Extreme_Weight-vs-Obese |
6.943500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.768200E-01 |
| Obese-vs-Extreme_Obese |
1.477240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.416400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.537600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.794400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.416300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.572200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.492200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.799600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.094600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.119700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.966260E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.978800E-04 |
| Normal-VS-Type2 PRCC |
5.694400E-01 |
| Normal-VS-KIRP CIMP |
7.515400E-03 |
| Normal-VS-Unclassified PRCC |
5.174200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.857360E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.318800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.982400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.19960000000086E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.488400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.263400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.097600E-02 |
| Normal-vs-N1 |
5.515900E-03 |
| Normal-vs-N2 |
7.270600E-01 |
| N0-vs-N1 |
9.389500E-04 |
| N0-vs-N2 |
2.378000E-01 |
| N1-vs-N2 |
3.889200E-01 |
|
|
